Endo International (ENDP) Tops Q4 EPS by 16c; Guides FY18 Below Views

Endo International (NASDAQ: ENDP) reported Q4 EPS of $0.77, $0.16 better than the analyst estimate of $0.61. Revenue for the quarter came in at $769 million versus the consensus estimate of $760.09 million.

GUIDANCE:

Endo International sees FY2018 EPS of $2.15-$2.55, versus the consensus of $2.86. Endo International sees FY2018 revenue of $2.6-2.8 billion, versus the consensus of $3.03 billion.

For earnings history and earnings-related data on Endo International (ENDP) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• Okta, Inc. (OKTA) Tops Q2 EPS by 8c; offers guidance
• Agilent Technologies (A) Tops Q3 EPS by 13c, Beats on Revenue; Offers FY EPS Guidance